when does the patent for semaglutide expire Ozempic's Protection Starts to in 2026. What Next? 'Indian Discount': Why Semaglutide is

BY RHEE ESTHER [[email protected]] This article was originally written in Korean and translated by a bilingual reporter with the help of generative AI tools

Conclusions In conclusion, this large cohort study found that GLP1 receptor agonist treatment was not associated with a substantially increased risk of thyroid cancer over a mean follow-up of 3.9 years

Its long half-life of about 33 hours means that researchers have been flexible with when the doses are administered

If your dose becomes too high, you might experience symptoms of an overactive thyroid (iatrogenic hyperthyroidism), such as: Heart palpitations or a racing pulse